Gringeri A - Search Results

1

Adverse effects of treatment with porcine factor VIII.

Gringeri A, Santagostino E, Tradati F, Giangrande PL, Mannucci PM. Gringeri A, et al. Thromb Haemost. 1991 Mar 4;65(3):245-7. Thromb Haemost. 1991. PMID: 1904652

2

Immune status of asymptomatic HIV-infected hemophiliacs: randomized, prospective, two-year comparison of treatment with a high-purity or an intermediate-purity factor VIII concentrate.

Mannucci PM, Gringeri A, de Biasi R, Baudo F, Morfini M, Ciavarella N. Mannucci PM, et al. Among authors: gringeri a. Thromb Haemost. 1992 Mar 2;67(3):310-3. Thromb Haemost. 1992. PMID: 1353642 Clinical Trial.

3

Failure of recombinant activated factor VII during surgery in a hemophiliac with high-titer factor VIII antibody.

Gringeri A, Santagostino E, Mannucci PM. Gringeri A, et al. Haemostasis. 1991;21(1):1-4. doi: 10.1159/000216194. Haemostasis. 1991. PMID: 1907588

4

The use of recombinant factor VIII in the management of hemophilia.

Mannucci PM, Gringeri A. Mannucci PM, et al. Among authors: gringeri a. Ric Clin Lab. 1991 Jan-Mar;21(1):1-7. doi: 10.1007/BF02919111. Ric Clin Lab. 1991. PMID: 1907760

5

Use of recombinant factor VIII in the management of hemophilia.

Mannucci PM, Gringeri A, Cattaneo M. Mannucci PM, et al. Among authors: gringeri a. Curr Stud Hematol Blood Transfus. 1991;(58):46-51. doi: 10.1159/000419336. Curr Stud Hematol Blood Transfus. 1991. PMID: 1954773 Review. No abstract available.

6

High-purity factor VIII concentrates produced without using monoclonal antibodies.

Mannucci PM, Gringeri A, Cattaneo M. Mannucci PM, et al. Among authors: gringeri a. Ric Clin Lab. 1990 Oct-Dec;20(4):227-37. doi: 10.1007/BF02900707. Ric Clin Lab. 1990. PMID: 2127470

7

Patterns of immunogenicity of an inactivated hepatitis A vaccine in anti-HIV positive and negative hemophilic patients.

Santagostino E, Gringeri A, Rocino A, Zanetti A, de Biasi R, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Thromb Haemost. 1994 Oct;72(4):508-10. Thromb Haemost. 1994. PMID: 7878624

8

Markers of hypercoagulability in patients with hemophilia B given repeated, large doses of factor IX concentrates during and after surgery.

Santagostino E, Mannucci PM, Gringeri A, Tagariello G, Baudo F, Bauer KA, Rosenberg RD. Santagostino E, et al. Among authors: gringeri a. Thromb Haemost. 1994 Jun;71(6):737-40. Thromb Haemost. 1994. PMID: 7974341 Clinical Trial.

9

Inhibitors to factor VIII in a family with mild hemophilia: molecular characterization and response to factor VIII and desmopressin.

Santagostino E, Gringeri A, Tagliavacca L, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Thromb Haemost. 1995 Aug;74(2):619-21. Thromb Haemost. 1995. PMID: 8584995

10

A prospective clinical trial of implantable central venous access in children with haemophilia.

Santagostino E, Gringeri A, Muça-Perja M, Mannucci PM. Santagostino E, et al. Among authors: gringeri a. Br J Haematol. 1998 Sep;102(5):1224-8. doi: 10.1046/j.1365-2141.1998.00909.x. Br J Haematol. 1998. PMID: 9753049 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

192 results

Search Page

Filters